| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
| filingDate |
2001-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1035a217ac57a36f7f237bf59ccd92c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32391731b3636e5c62df650d959c2b20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2186718387b306b512f0631fea231074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80823be1fabdc9846bc9f83d52e75e8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22b258f8783611f734e4cd7c77706888 |
| publicationDate |
2003-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003013854-A1 |
| titleOfInvention |
High affinity humanized anti-TAG-72 monoclonalantibodies |
| abstract |
Novel humanized monoclonal antibodies, humanized antibody fragments, and derivatives thereof which specifically bind TAG-72 are provided as well as methods for their manufacture. These humanized antibodies are useful in the treatment of cancers which express TAG-72 as well as for diagnostic purposes, e.g., for in vivo imaging of tumors or cancer cells which express TAG-72. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10645049-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018302361-A1 |
| priorityDate |
1996-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |